Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China's Healthcare and Drug Spending Still Growing despite Relentless Cost Cutti...
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this issue's emphasis on latest regulatory developments and major healthca... (12/6/2016)
   
China's Healthcare and Drug Spending Still Growing despite Relentless Cost Cutting (12/6/2016)
China's Health Care Reforms Set to Benefit Top Domestic Pharmas (12/5/2016)
IPR Protection Strategies within the Healthcare Sector in China (12/2/2016)
Biopharmaceutical Manufacturing Growing Rapidly in China (12/1/2016)
AstraZeneca Gets Shot in the Arm with China Market (12/1/2016)
China Looks Offshore to Inject New Life into Ailing Domestic Drug Industry (12/1/2016)
How Pharma Companies Can Keep Winning in China’s Changing Market (12/1/2016)
Balancing Act: China's Online Healthcare System Needs Both Innovation And Regulation (11/30/2016)
Facing A 'Tidal Wave' of Dementia, China Is Running Out of Time (11/26/2016)
Pfizer, Astrazeneca Outpace Big Pharma in Emerging Markets as Growth Ticks Upward (11/26/2016)
SIPO Revises Chinese Patent Examination Regulations (11/24/2016)
Telemedicine Services Reimbursable in Guizhou Province of China (11/17/2016)
Corporate Private Eyes Accuse Glaxo of Taking Actions That Led To Their Imprisonment (11/17/2016)
The Heat is On for the Chinese Pharmaceutical Industry (11/14/2016)
Roche Group Looks to Grow and Change with China's Ever-evolving Healthcare Industry (11/10/2016)
NDRC Fines MedTronic CNY 118.5M for Alle...  (12/7/2016)
Elsevier: China's Cancer Research Advanc...  (12/7/2016)
Kelun Pharma to Set Up Another R&D S...  (12/7/2016) (free)
Pharma MNC's China Performance Rose Only...  (12/6/2016)
BMS Terminates OTC Business Division in ...  (12/6/2016)
CFDI Solicits Comments on New Technical ...  (12/6/2016)
CDE Seeks Public Comments on Draft Drug ...  (12/6/2016)
Zhejiang Huahai’s Unit Buys Charlotte F...  (12/6/2016)
BioAtla and Sinobioway Select First Four...  (12/6/2016)
Chinese Scientists Create Live-Virus Vac...  (12/5/2016) (free)
CFDA Accepts CASI Pharma's Import Drug A...  (12/5/2016)
Chinese Ex-Hospital Prescription Drug Sa...  (12/5/2016)
Nicholas Hall Reports Growth of Chinese ...  (12/5/2016)
Sanofi, JHL Biotech Forms Strategic Part...  (12/5/2016)
CR Sanjiu, Sanofi Enter Strategic Allian...  (12/5/2016)
New Pharma Rankings On Global Access To Medicine Release...
Top Three TCs Account for 68% of Overall Global Pharma I...
Sanofi, Boehringer Ingelheim Agree to Swap Business Asse...
Novartis Splits Pharmaceuticals Division Into Two Busine...
IMS Health Holdings and Quintiles to Combine
Chinese Ex-Hospital Prescription Drug Sales Forecasted to Excee...
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Mar...
SMEI: Chinese Pharma e-Commerce to Continue High Growth
SMEI Reports Pharma Industry Performance in 3Qs of 2016
Sinohealth: Chinese Biologic Product Market and Its Top 10 Prod...
Kelun Pharma to Set Up Another R&D Subsidiary in the U.S...
Pharma MNC's China Performance Rose Only 4% on Average in Q3...
BMS Terminates OTC Business Division in China
Zhejiang Huahai’s Unit Buys Charlotte Facility from Par Pha...
BioAtla and Sinobioway Select First Four Programs for China ...
CFDI Solicits Comments on New Technical Guideline Docume...
CDE Seeks Public Comments on Draft Drug Evaluation Docum...
CFDA Solicits Public Comments for Draft Amendment of GCP...
CFDI Announces Latest Clinical Data Inspection Plan
CDE Grants Priority Review Status to 32 Drug Registratio...
NDRC Fines MedTronic CNY 118.5M for Alleged Price-fixing
China Releases New Guideline to Boost Property Right Protect...
GSK Agrees to Pay $20M Settling for China Bribery Allegation...
US Court Threw Out China Vitamin C Price Fixing Decision
AstraZeneca to Pay Over $5M to Settle with USSEC for Alleged...
U.S. FDA Warns Chinese Heparin Producer Dongying Tiandon...
India Puts Chinese APIs on Radar over Quality Concerns
U.S. FDA Warns Yet Another Chinese API Manufacturer for ...
India Agitated by Large Scale API Import from China, Cal...
FDA Bans Import from Another Chinese Drug Manufacturer
Elsevier: China's Cancer Research Advances, Closing In w...
Chinese Scientists Create Live-Virus Vaccines to Tackle ...
MicuRx Initiates Phase 1 Clinical Trial in U.S. for Nove...
CBMG to Commence Phase I Trial in China for Non-Hodgkin ...
Suven Life Sciences Granted One More NCE Product Patent ...
Beijing Uniforms BMI Drug Reimbursement of Hospitals and...
China Sees Continued Rising HIV/AIDS Cases in 2016
Zhejiang Introduces New Public Hospital Drug Purchase Po...
Shanxi Province Introduce Implementation Plan for Merger...
New England Journal of Medicine Publishes Chinese Editio...
Recent Executive Moves
Senior Local Health Official Investigated for Corruption
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: 15th Annual eyeforpharma Barcelona 2017
Upcoming Event: 3rd Annual Asia Healthcare Summit 2017
Upcoming Event: 9th Annual AsiaTides
Upcoming Event: Biopharma Development and Production Wee...
Upcoming Event: 2nd Annual PharmaCon China 2017
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links